[Updated] UK SACT Board: Good Practice Guidance for Immuno-Oncology Medicines
UK SACT Board
Good Practice Guidance for Immuno-Oncology Medicines – May 2024
The UK SACT Board’s Good Practice Guidance for Immuno-Oncology Medicines has been updated.
This guideline is designed to give a practical framework for the safe introduction and ongoing use of immunotherapy in existing Systemic Anti-Cancer Therapy (SACT) services.
This guideline is available on the UK SACT Board publication page: https://www.uksactboard.org/publications